The industry experienced aggressive growth during the past five years as operators have worked to provide clients with a full-service experience, from product conception to approval, enabling contract research organizations to shorten drug or device development cycles. Furthermore, industry services have been particularly attractive to manufacturers because of the cost savings they provide in the midst of tight economic conditions. During the next five years, the industry is forecast to continue growing, driven by rising demand from biopharmaceutical companies.
This industry includes companies that provide research services on a contract basis to the pharmaceutical and biotechnology industries. Contract research organizations (CRO) provide biopharmaceutical development, preclinical research, clinical research and clinical trial management. Many CROs specifically provide clinical study and clinical trial support for drugs or medical devices.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.